EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Pharmaceutical Quality Systems in the U.S.: GMP, Quality Control and Manufacturing Compliance
Most people never think about the quality system behind their medicine They open a bottle take a tablet and trust it That trust is built on a huge amount of unglamorous work documentation testing audits and people who say stop the line when something looks off
-
Techno Trends
Glycomine’s GLM101 Receives FDA Breakthrough Therapy Designation
Glycomine has received Breakthrough Therapy designation from the US Food and Drug Administration FDA for GLM an investigational treatment for phosphomannomutase congenital disorder of glycosylation PMMCDG a rare multisystem disorder with no approved therapies
-
Projects
Hovione Opens US$100 milllion East Windsor Pharma Manufacturing Expansion
Pharmaceutical CDMO Hovione has opened a new squarefoot facility at its East Windsor campus in New Jersey completing its current US million US investment programme The expansion doubles Hoviones US spraydrying capacity and strengthens its pharmaceutical development
-
Research Insights
Salivary and serum levels of NT-proBNP, troponin, and high-sensitivity C-reactive protein in patients with heart failure
Saliva has been proposed as a noninvasive biological matrix for cardiovascular biomarker assessment However evidence regarding its agreement with bloodbased measurements in patients with heart failure remains inconsistent
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Advancements in Biomedicine and Pharmacotherapy: A Comprehensive Overview
Kate Williamson
Recent advancements in biomedicine and pharmacotherapy have revolutionized healthcare through precision medicine, immunotherapy, regenerative medicine, and artificial intelligence. These transformativ...
-
2
How Do Stem Cell Therapy Treat Human Diseases?
Kate Williamson
Modern medical therapy succeeds through stem cell technology that provides regenerative treatments for diabetes patients as well as those with autoimmune disorders and cardiovascular diseases and neur...
-
3
Biosimilar Market Access: Why Execution Gaps Cost Companies Hundreds of Millions
Doug Drysdale
The biosimilar market has generated over USD 56.2 billion in savings since 2015, yet many biosimilar companies systematically underperform on market access. This article examines four critical failure...
-
4
Is Digital Transformation the Key to Pharma's Operational Excellence?
Kate Williamson
The pharmaceutical industry is undergoing a profound shift with the adoption of digital transformation, offering opportunities for operational excellence. Key aspects include data-driven decision-maki...
-
5
The Future of Pharma: Integrating Imaging Informatics for Better Outcomes
Kate Williamson
Imaging informatics revolutionizes the pharmaceutical industry by integrating advanced imaging techniques with data analytics to enhance drug discovery, personalize treatments, and improve patient out...
press releasesRead more...
Repligen completes acquisition of BioLife Solutions
Repligen Corporation NASDAQ RGEN Repligen or the Company a life sciences company focused on bioprocessing technology leadership today announced it has completed the previously announced
Electron Bio Launches FAST GMP™ Modular Cleanroom Platform and FAST QMS™
Electron Bio today launched FAST GMP its patentpending modular cleanroom platform for cGMP manufacturing together with FAST QMS and CMC services Electron Bio conceived and designed
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
ORIC Pharmaceuticals Inc Nasdaq ORIC a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Pacira BioSciences Inc NASDAQ PCRX the industry leader in its commitment to deliver innovative nonopioid pain therapies to transform the lives of patients today announced a strategic partnership with Molteni
Events Read more...
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
LATEST NEWSRead more...
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio and TychoBio have announced a collaboration to generate fulllength RNA data for training artificial intelligence AI models that support the design of RNA therapies for rare diseases
Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programmes
Relay Network and Claritas Rx have announced a strategic partnership to help life sciences companies improve patient access support and treatment adherence across specialty and rare disease programmes
Psyence BioMed Partners with Benuvia to Establish U.S. Manufacturing of Pharmaceutical-Grade Ibogaine
Psyence Biomedical Ltd Nasdaq PBM through its wholly owned Texas subsidiary Texas Ibogaine Research Corporation TIRC has entered into a manufacturing services agreement with Benuvia Operations
Italfarmaco and VeriSIM Life Partner to Develop HDAC-Targeted Therapies for Neuromuscular and Rare Diseases
Italfarmaco SpA and VeriSIM Life have entered into a strategic collaboration to discover and develop novel histone deacetylase HDACtargeted therapies for neuromuscular fibrotic and rare diseases
Bayer to invest $2.2 billion in new US pharmaceutical manufacturing site
Bayer plans to invest billion in a new pharmaceutical manufacturing site in New Albany Ohio in the United States The project is part of the companys longterm growth strategy and will support its focus on innovation and patient access in the US pharmaceutical market
Italfarmaco and JCR Pharmaceuticals sign exclusive licence agreement for Hunter syndrome therapy
Italfarmaco and JCR Pharmaceuticals have entered into an exclusive licence agreement to develop and potentially commercialise JR in the United States Europe and Latin America subject to regulatory approval
